NYU-Poly scientists develop a new method of protein stabilization

Scientists at the Polytechnic Institute of New York University report they have developed a novel method of stabilizing proteins, including important enzymes used to produce certain artificial sweeteners and bio-ethanol. The research will also be useful for extending the lifetime of therapeutic proteins employed to diagnose illnesses.

The NYU-Poly scientists inserted the unstable exoinulinase (EI) protein into a thermophilic scaffold protein, which is known for its stability and a propensity to protect less stable proteins. The method developed by the NYU-Poly scientists stabilizes EI without compromising its enzymatic ability; in other words, its ability to act as a catalyst to enhance certain chemical reactions. In the past, EI proteins lost their enzymatic activity too rapidly to be useful in turning the abundant plant sugar inulin into ultra-high fructose syrup or bio-ethanol.

The method can potentially be applied to a wide range of unstable proteins for therapeutic purposes, such as diagnosis of illnesses using proteins.

“Enzyme Stabilization by Domain Insertion into a Thermophilic Protein” was published in the journal Protein Engineering, Design and Selection (October 2009). The first author is Chung-Sei Kim, a post doctoral researcher working under Jin Ryoun Kim, an assistant professor in NYU-Poly’s Chemical and Biological Engineering Department. Brennal Pierre, a PhD graduate student in Kim’s laboratory, was one of the coauthors. They have applied for a provisional patent.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Targeted degradation of Pin1 shows promise for pancreatic cancer treatment